French Healthcare Association and Business France are delighted to introduce the first edition of the French exportable solutions in the field of oncology chart. Innovation and excellence in the field of prevention, screening, care and follow-up of cancer patients are finally brought together in a single document.
Cancer is the leading cause of preventable death in the world, since it is currently estimated that nearly one cancer death in two could be prevented. This is why, for the first time, the French Healthcare Association is proposing a chart of the French cancer care offer to disseminate innovation and excellence in cancer care to as many people as possible.
Exportable human and industrial expertise
Over the past 20 years, French cancer plans have become models for mobilizing all resources, from research to care, to reduce cancer mortality. France remains at the forefront of progress by creating a favorable ecosystem to meet the challenges of personalized medicine development.
In support of this ambition, twelve of the eighteen French cancer centers are ranked among the best hospitals specialized in oncology in the world. Among them, two are in the top 50: Gustave Roussy 5th and the Institut Curie 31st.
Oncology education : a strategic tool
Training is a strategic tool for improving the quality of care. France disseminates its know-how internationally through numerous training courses for international professionals in its most prestigious hospitals and institutes.
The French healthcare industry offers exportable industrial solutions in many fields as varied as drugs, medical devices, telemedicine or information systems…
Welcoming international patients
The leading pathology treated in France for international patients is cancer. Thanks to one of the most stringent quality and safety certification systems in the world, the creation of the myfrenchhospital.com website, which describes what France has to offer, and the implementation of the “French Hospital Quality” label for facilities receiving foreign patients, France offers a benchmark healthcare system among OECD countries in terms of access to care. It ranks 5th in the world for the quality of its healthcare infrastructure.
France’s commitment to the fight against cancer is supported by all the players involved and international influence is at the heart of the actions undertaken: research, patient care, development of new drugs, technologies, training and support for patients.
French oncology research recognized worldwide
France benefits from the presence of world-renowned academic, industrial and clinical players such as Inserm, which is ranked 9th in the world among the most innovative research institutes.
The dynamism of cancer research is reflected in the quality and number of publications, which ranks France 2nd in Europe and 4th in the world for clinical trials in cancer.